1-15112518-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_201628.3(KAZN):c.2140G>A(p.Gly714Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000685 in 1,604,994 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_201628.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KAZN | NM_201628.3 | c.2140G>A | p.Gly714Ser | missense_variant | 14/15 | ENST00000376030.7 | NP_963922.2 | |
TMEM51-AS1 | NR_027136.1 | n.6276C>T | non_coding_transcript_exon_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KAZN | ENST00000376030.7 | c.2140G>A | p.Gly714Ser | missense_variant | 14/15 | 5 | NM_201628.3 | ENSP00000365198 | P2 | |
TMEM51-AS1 | ENST00000310916.6 | n.6397C>T | non_coding_transcript_exon_variant | 6/6 | 2 | |||||
TMEM51-AS1 | ENST00000404665.4 | n.6270C>T | non_coding_transcript_exon_variant | 5/5 | 1 | |||||
KAZN | ENST00000636203.1 | c.2404G>A | p.Gly802Ser | missense_variant | 16/17 | 5 | ENSP00000490958 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000666 AC: 1AN: 150066Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000687 AC: 10AN: 1454928Hom.: 0 Cov.: 34 AF XY: 0.00000692 AC XY: 5AN XY: 722832
GnomAD4 genome AF: 0.00000666 AC: 1AN: 150066Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 73202
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2023 | The c.2140G>A (p.G714S) alteration is located in exon 14 (coding exon 14) of the KAZN gene. This alteration results from a G to A substitution at nucleotide position 2140, causing the glycine (G) at amino acid position 714 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at